Johnson & Johnson faces $344M penalty for misleading pelvic mesh claims

Date: 2020-02-04   Author: Pankaj Singh  Category: #news

Johnson & Johnson faces $344M penalty for misleading pelvic mesh claims

A California judge has recently ordered Johnson & Johnson to pay penalties worth nearly $344 million for deceptively marketing pelvic mesh products for women. Eddie Sturgeon, a judge for the Superior Court of San Diego, passed the judgement for Johnson & Johnson to pay the fine. The state had initially asked for an amount of $800 million.

A pelvic mesh, also known as the transvaginal mesh, is a woven synthetic netting used to treat POP (pelvic organ prolapse) and SUI (stress urinary incontinence) in women. The product helps reinforce weakened vaginal walls and supports the urethra or bladder neck.

The pharmaceutical company faced the lawsuit over allegations that Ethicon, the company’s subsidiary, failed to inform doctors and patients about the adverse effects and misrepresented the severity and frequency of risks posed by pelvic mesh products.

In the list of instructions for use of pelvic mesh products, the company allegedly excluded to mention the possible side-effects and complications that may arise, instead vividly highlighting the benefits of the firm’s products, despite the potentially grievous risks involved.

According to a spokesperson, J&J has not admitted the misconduct and will appeal the ruling, asserting the California Department of Justice failed to present evidence as proof of its claims.

J&J spokesperson, Mindy Tinsley, claims that the decision to file a lawsuit to the company is inappropriate, stating that it disregards the company’s full compliance with the U.S. Food and Drug Administration regulations. She further added that Ethicon’s surgical products unit responsibly discussed with doctors and patients regarding the risks as well as benefits of the pelvic mesh products.

Recent records of legal issues faced by the company also include similar allegations over products side-effects and deceptive marketing, which led to a settlement charge of $177 Mn with over 41 states as well as the District of Columbia.

Source credit:

https://thehill.com/policy/healthcare/480782-johnson-johnson-ordered-to-pay-344-million-over-surgical-mesh-claims



About Author


Pankaj Singh linkdin-boxtwitter

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

Post Recommendents

Glucosinolates Market Valued at USD 140 million in 2018 | Trends, Competitive Landscape, Geographical Overview

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Glucosinolates market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the business into...


Industrial Margarine Market Segmentation Analysis, Competitive Outlook, Growth Factors and Forecast till 2026

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Industrial Margarine market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the busines...


Grapeseed Oil Market Valued at USD 410 million in 2018 | Trends, Competitive Landscape, Geographical Overview

Author: Rahul Varpe

DecResearch Inc. published a comprehensive study on the Grapeseed Oil market. The report cover the top trends in the industry, key players, major segments, geographical analysis and some of other parameters that support to drive the business into ...